STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3735 by analyst upside · 2026-06-27
INMD
InMode Ltd.
Healthcare · Market Cap $841M · P/E 10.8x
ANALYST PRICE TARGET
-2.0%
implied upside to consensus target
Current Price $14.63
Consensus Target $14.33
Bull Target $15.0
Bear Target $14.0
Analysts Covering 3
ANALYST CONSENSUS — UNDERPERFORM
Strong Buy
0
Buy
0
Hold
2
Sell
1
52-Week Low $12.72
52-Week High $16.74
YTD Return -1.1%
FUNDAMENTALS
Market Cap $841M
P/E Ratio (TTM) 10.8x
Forward P/E 10.1x
EPS (TTM) $1.35
PEG Ratio 0.83
Dividend Yield N/A
Revenue (TTM) $375M
Profit Margin 23.3%
52-WEEK RANGE
52-Week Low $12.72
52-Week High $16.74
Current Price $14.63
Bear Target $14.0
Bull Target $15.0
● Now $14.63 ● Target $14.33
TRADING DATA
Avg Volume 844K
YTD Return -1.1%
Analyst Count 3
Consensus Underperform
Upside to Target -2.0%
Last Updated 2026-06-27

ANALYST SUMMARY

InMode Ltd. (INMD) is currently trading at $14.63 with a Wall Street consensus price target of $14.33, which is 2.0% below the current price over the next 12 months. 3 analysts currently cover INMD, with a consensus rating of Underperform — 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $14.0.

INMD operates in the Healthcare sector with a market capitalisation of $841M. The stock is down 1.1% year-to-date and is currently trading near the lower end of its 52-week range of $12.72 – $16.74.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for INMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Overweight → Overweight 2026-05-07 Building track record
Baird — Reiterated
Neutral → Neutral 2026-05-07 Building track record
Canaccord Genuity — Reiterated
Hold → Hold 2025-12-17 Building track record
UBS — Reiterated
Neutral → Neutral 2025-11-06 33% win rate (6 calls)
Canaccord Genuity — Reiterated
Hold → Hold 2025-10-10 Building track record
Needham reit
Hold → Hold 2025-10-10 20% win rate (5 calls)
Needham reit
Hold → Hold 2025-07-30 20% win rate (5 calls)
Barclays — Reiterated
Overweight → Overweight 2025-07-30 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
11/30
Consensus clarity
29/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →